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Abstract
Background: In recent years, the incidence of several pathogens of public health importance (measles, mumps,
pertussis and rubella) has increased in Europe, leading to outbreaks. This has included England, where GP practices
implement the vaccination programme based on government guidance. However, there has been no study of how
implementation takes place, which makes it difficult to identify organisational variation and thus limits the ability to
recommend interventions to improve coverage. The aim of this study is to undertake a comparative process
evaluation of the implementation of the routine vaccination programme at GP practices in England.
Methods: We recruited a sample of geographically and demographically diverse GP practices through a national
research network and collected quantitative and qualitative data as part of a Time-Driven Activity-Based Costing
analysis between May 2017 and February 2018. We conducted semi-structured interviews with practice staff
involved in vaccination, who then completed an activity log for 2 weeks. Interviews were transcribed and coded
using a framework method.
Results: Nine practices completed data collection from diverse geographic and socio-economic contexts, and 52
clinical and non-clinical staff participated in 26 interviews. Information relating to 372 vaccination appointments
(233 childhood and 139 adult appointments) was captured using activity logs. We have defined a 14-stage care
delivery value chain and detailed process map for vaccination. Areas of greatest variation include the method of
reminder and recall activities, structure of vaccination appointments and task allocation between staff groups. For
childhood vaccination, mean appointment length was 15.9 min (range 9.0–22.0 min) and 10.9 min for adults (range
6.8–14.1 min). Non-clinical administrative activities comprised 59.7% total activity (range 48.4–67.0%). Appointment
length and total time were not related to coverage, whereas capacity in terms of appointments per eligible patient
may improve coverage. Administrative tasks had lower fidelity of implementation.
Conclusions: There is variation in how GP practices in England implement the delivery of the routine vaccination
programme. Further work is required to evaluate capacity factors in a wider range of practices, alongside other
contextual factors, including the working culture within practices.
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Background
The introduction of vaccinations into public health pro-
grammes in European countries over the last century
has resulted in a dramatic reduction in vaccine prevent-
able diseases (VPDs), including the elimination of small-
pox and polio from the region. However, in recent years,
the incidence of several pathogens of public health im-
portance such as measles, mumps, pertussis and rubella
has increased in Europe [1]. Coverage of the combined
measles, mumps and rubella vaccine (MMR) is below
herd immunity thresholds in many European countries,
and in 2018, several countries such as Italy, Greece,
France, Romania and the UK were affected by outbreaks
[2, 3]. The causes of disparities in coverage are complex,
multifactorial and country-specific but include suboptimal
delivery mechanisms, alongside inequities in access for
some populations, particularly those living in low-income
urban environments [1, 4, 5].
In England, primary care clinics (GP practices) are re-
sponsible for arranging most routine childhood and
adult vaccinations for their local population. The regular
addition of antigens into routine vaccine programmes
has meant organising service delivery has become in-
creasingly complex [6]. In 1990, the programme con-
sisted of eight vaccinations for children and adolescents
against diphtheria, pertussis, tetanus, polio, measles,
mumps, rubella and tuberculosis [7]. The programme
for 2016–2017 (study period) and changes for 2018 are
presented in Table 1 and now contains 16 childhood, 2
adolescent and 3 adult vaccinations, as well as 2 in
pregnancy and a wide range for people with medical
co-morbidities [8].
Delivering these vaccinations has required an increase
in the number of contacts needed with the healthcare
system for a wider range of patients, alongside associated
administrative activities, including reminding and recal-
ling patients and collecting and submitting data. These
activities add significantly to the cost base of a practice
and have taken place contemporaneously with increasing
demand for GP services from an ageing population with
more complex health needs, without commensurate in-
creases in funding or staffing [9]. In addition, the public
health system in England underwent a dramatic reorga-
nisation in 2013 following the implementation of the
Health and Social Care Act 2012. This moved local
public health functions from NHS providers into local
government, created a new executive agency for public
health within the Department of Health called Public
Health England and moved commissioning of public
health services to a new agency called NHS England, with
the aim of putting ‘clinicians at the centre of commission-
ing, free[ing] up providers to innovate, empower[ing] pa-
tients and giv[ing] a new focus to public health’ [10].
However, this had unintended consequences for the
vaccination programme, resulting in a ‘complex mesh’
of ‘fractured’ commissioning, policy and service
provision organisations and reduced oversight and
support [11].
Vaccination is a highly complex public health programme
with multiple interdependent activities which currently ex-
hibits divergent outcomes [12]. Routine coverage statistics
derived from GP practice records show that while
coverage for childhood vaccinations remains relatively
high, there have been multi-year decreases in coverage
across many vaccines (Fig. 1) [13]. While this could be
a result of expected fluctuations, coverage had previ-
ously been on an upward trend for most vaccines over
the preceding decade. Further year-on-year decreases
may result in coverage for some vaccines reducing
below international targets (> 95% coverage) and popu-
lation immunity thresholds to prevent outbreaks (> 90%
coverage). For example, MMR at 24 months increased
every year between 2007-2008 and 2012-2013 and, how-
ever, has now reduced from a high of 92.7% (2013–2014)
to 91.6%. The decreases shown for the DTaP/IPV booster
and MMR at 5 years may mean the > 90% target will not
now be reached. This is particularly concerning for the
measles-containing vaccines in the context of current
large outbreaks in several European countries and five UK
locations [2, 3].
National averages also hide significant geographic in-
equities. For example, coverage is significantly lower in
London than elsewhere in England (e.g. in 2016–2017
DTaP-IPV-Hib 12 months: England 93.4%, London
88.8%; MMR2 5 years: England 87.6%, London 79.5%).
There is also lower coverage in some ethnic groups
and in areas of higher deprivation [14, 15]. The causes
for this are unclear at present, and this study aims to
provide more information about what is happening at
GP practice level.
Previous research has shown that lower adherence to
programme components is associated with worse out-
comes for prevention services [16]. GP practices are
independent providers contracted to provide vaccine
services by NHS England, which defines minimum ser-
vice standards for vaccination in the core service spe-
cification [17]. The specification leaves significant
autonomy to practices as to how they organise imple-
menting the programme. The National Institute for
Health and Care Excellence (NICE) has also published
quality standards for aspects of vaccination programme
delivery for children and adolescents [18]. However, it is
currently not known how different practices implement
the programme, i.e. how activities are managed, nor
whether the quality standards are adhered to. This makes
it difficult to identify organisational variation and thus
limits the ability to recommend interventions to improve
coverage. Therefore, the aim of this study is to undertake
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a comparative process evaluation of the implementation
of the routine vaccination programme at GP practices in
England.
Methods
We collected quantitative and qualitative process data
in line with the Medical Research Council’s process
evaluation guidance as part of Time-Driven Activity-
Based Costing (TDABC) analysis [12]. TDABC is a
method for allocating costs to complex processes within
organisations to identify cost drivers and opportunities for
lowering costs while improving quality [19–21], which
has been extensively applied to complex health service
delivery in primary and secondary care [21]. Steps 1–4
Table 1 The 2016–2017 routine vaccine programme in England, adapted from Public Health England (2018) [8]
Age Disease(s) Vaccine (trade name) Notes, including schedule changes
implemented during the study period
8 weeks Diphtheria, tetanus, pertussis, polio,
Haemophilus influenza type b (Hib)
DTaP/IPV/Hib (Pediacel or Infanrix
IPV Hib)
Changed to Infanrix Hexa, with hepatitis B
(Hep B) included in 2018
Pneumococcal (13 serotypes) Pneumococcal Conjugate (PCV)
(Prevenar 13)
Meningococcal group B (MenB) MenB (Bexsero)
Rotavirus Rotavirus (Rotarix)
12 weeks Diphtheria, tetanus, pertussis,
polio and Hib
DTaP/IPV/Hib (Pediacel or Infanrix
IPV Hib)
Changed to Infanrix Hexa, with hepatitis B
(Hep B) included in 2018
Rotavirus Rotavirus (Rotarix)
16 weeks Diphtheria, tetanus, pertussis,
polio and Hib
DTaP/IPV/Hib (Pediacel or Infanrix
IPV Hib)
Changed to Infanrix Hexa, with hepatitis B
(Hep B) included in 2018
MenB MenB (Bexsero)
Pneumococcal (13 serotypes) PCV (Prevenar 13)
1 year Hib and MenC Hib/MenC booster (Menitorix)
Pneumococcal 13 PCV Booster (Prevenar 13)
Measles, mumps and rubella (MMR) MMR (VaxPRO or Priorix)
MenB MenB booster (Bexsero)
2–6 years Influenza (seasonal) Live attenuated influenza vaccine
(LAIV) (Fluenz Tetra)
Seasonal vaccine—excluded from this study
From 3 years 4 months Diphtheria, tetanus, pertussis
and polio
DTaP/IPV (Infanrix IPV or Repevax)
MMR MMR (VaxPRO or Priorix)
Females 12–13 years Human papillomavirus (HPV) HPV (two doses 6 to 24 months
separated) (Gardasil)
Usually given in school—excluded from this
study unless given in the GP practice
14 years Tetanus, diphtheria and polio Td/IPV (Revaxis) Usually given in school—excluded from this
study unless given in the GP practice
Meningococcal groups A, C, W
and Y
Men ACWY (Nimenix or Menveo) Usually given in school—excluded from this
study unless given in the GP practice
65 years Pneumococcal (23 serotypes) Pneumococcal polysaccharide
(PPV) (Pneumovax II)
> 65 years Influenza (seasonal) Inactivated influenza vaccine
(strain dependent)
Seasonal vaccine—excluded from this study
70 years Shingles Shingles (Zostavax)
Condition Disease(s) Vaccine (trade name) Notes
Pregnancy Influenza (seasonal) Inactivated influenza vaccine
(strain dependent)
Seasonal vaccine—excluded from this study
Pertussis DTaP/IPV (Boostrix-IPV) From 16 weeks gestation
Various underlying medical
conditions
Meningococcal
Pneumococcal
Influenza
Hepatitis A and B
HiB
Various Patients with a wide range of medical
conditions (asplenia, diabetes, respiratory,
neurological) are eligible for a range
of vaccines
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of the 7-step TDABC analysis generate process evalu-
ation data [22]. Steps 5–7 involve calculation and allo-
cation of costs and are excluded from this analysis.
Qualitative components of this study have been re-
ported in line with COREQ guidelines [23].
– Step 1: Define the condition and population
The condition under analysis is a patient registered
at a GP practice who is eligible for a routine vaccin-
ation. The organisational boundary of this analysis is
those activities that are undertaken within the GP
practice by employees. Patients attending for all rou-
tine childhood and adult vaccinations were included
(Table 1), except seasonal influenza, as this is funded
through a different mechanism and activity is uneven
throughout the year. Non-routine vaccines (e.g. travel
vaccinations) and vaccines not given in GP practices
(e.g. HPV vaccine given at school) were also excluded.
– Steps 2 and 3: Define the delivery value chain and
develop a process map
The care delivery value chain (CDVC) is a visual
representation of the main activities involved in pro-
viding routine vaccinations at GP practices [21, 22].
To define the CDVC, we conducted semi-structured
interviews using primarily open questions with a se-
lection of staff from each practice (individually or in
groups depending on availability) using a pre-defined
topic guide (Appendix). One author (TCB) conducted
all the interviews during a single day at each practice,
which were recorded, transcribed verbatim and
uploaded into NVIVO v11 for analysis. Contemporan-
eous field notes were made during site visits. Coding was
completed by one author (TCB) using a framework
method. A deductive code tree was constructed from core
process evaluation elements (inputs, processes, activities,
outputs, outcomes and impact) as well as temporal
associations within the implementation process (pre-
appointment, appointment, post-appointment) and age-
group codes (children and adults). Inductive codes were
used to identify important issues arising from the data
(e.g. funding, outbreaks, appointment length). During
the first pass, we coded all data using deductive codes
and generated the inductive codes. We then undertook
a second pass to universally apply the inductive codes
and check completeness and overall accuracy. The
framework and a selection of transcripts were reviewed
by a second author (SMJ) [24].
– Step 4: Allocate time estimates for each
process step
We provided all staff involved in vaccination at
each practice an activity log to contemporaneously
record all clinical and non-clinical vaccination activ-
ity over a 2-week period. We modified logs used in
a study conducted in New Zealand [25] and vali-
dated them with practice managers (PMs), practice
Fig. 1 Coverage (%) of selected vaccinations by age in England 2011–2017, from NHS Digital (2017) [11]
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nurses (PNs) and GPs at two non-participating prac-
tices. The first practice recruited was used as a pilot
before data collection tools were finalised following
minor changes to the interview guide and to the
data collection tools, primary for clarity and usabil-
ity. Following the interviews (step 2), a list of every
member of staff involved in vaccination was devel-
oped for each practice who were then trained and
provided with an activity log to keep for 2 weeks.
Data were extracted and placed into a Microsoft
Excel file for analysis.
Sampling
We recruited GP practices to participate through the
National Institute for Health Research Clinical Research
Network (CRN) [26]. This comprises an extensive
network of primary and secondary care organisations
in all regions of England, including more than 2000
GP practices, who apply to join a scheme of payment
for participating in research projects funded by the
Department of Health. We aimed to recruit a
non-representative convenience sample of 10 practices
(due to our available capacity) from a range of geo-
graphic and socio-economic contexts. Following circu-
lation of the study details, 14 practices retuned
expressions of interest to participate over a 9-month
period before recruitment was ended. We excluded 4
practices as they were geographically similar to
already included practices, and 1 did not complete
data collection. A £350 shopping voucher (£500 in
London) was provided to participating practices as
compensation for staff time. Agreement to participate
was made with the practice manager, who we then
asked to identify relevant members of staff to partici-
pate in interviews to explore the organisation of vaccin-
ation within the practice. Due to the significant
variation in size, staff profile and administrative organ-
isation between practices, we specified only that the
practice manager and a practice nurse must be in-
cluded, and the manager was then free to recruit other
relevant staff to participate based on the research aims.
Consent and ethical approval
We gained written, informed consent from each par-
ticipating staff member prior to commencing data
collection. No patients were involved. The study re-
ceived ethical approval from the LSHTM Ethics
Committee and the NHS Health Research Authority
(project ID 212278).
Results
Nine practices completed data collection activities be-
tween May 2017 and February 2018. Their characteris-
tics are presented in Table 2, which demonstrate wide
geographic and demographic diversity. Two quality met-
rics are routinely collected and reported at GP practice
level: Quality Outcomes Framework (QOF), a pay for
performance scheme in which vaccination is not in-
cluded (except influenza coverage in people with medical
co-morbidities), and the proportion of patients recom-
mending the practice to friends and family. All practices
aside from C and J score higher QOF points than aver-
age, and every practice scores higher on the friends and
family test, except F, which scores very low (56.6%). For
childhood vaccination coverage, the smaller practices
have higher than average coverage for most vaccinations
(A, B, C, D, E and F) whereas the three largest practices
(G, H and J), including the two in London, have lower
coverage, with practice G having the lowest coverage
overall. Adult vaccinations are similar with the smaller
practices scoring above average and the four larger prac-
tices (F, G, H and J) below with particularly low coverage
in practice J.
Care delivery value chain and process map
In total, 52 people participated in 26 interviews at the 9
practices. Interviews ranged from 10 to 75 min. The
number and type of staff who participated at each prac-
tice is presented in Table 3. In one practice, a GP pro-
vided oversight to the programme out of personal
interest (J), but otherwise, no doctors were involved in
vaccination.
Interview data were supplemented with the activity
log data to confirm details provided in the inter-
views, and information relating to 372 vaccination
appointments was captured, comprising 233 child-
hood and 139 adult appointments. The resulting
CDVC is presented in Fig. 2. Fourteen core activities
were common to all practices and took place within
the GP practice building, aside from the nurses’ an-
nual training, which was usually at another local or-
ganisation. Timings for three of the activities (dashed
boxes) were aggregated with other activities by some
practices. Although this is presented as a linear
process, these activities often take place concurrently
or non-sequentially creating a constant responsive
workflow. A process map from the perspective of the
practice is presented in Fig. 3.
Activities and task allocation
The task allocation of the activities shown in Figs. 2
and 3 is presented in Table 4. The role of the clinical
staff was similar across practices, with practice nurses
(PNs) having the primary role in delivering vaccina-
tions, with some also delivered to adults by healthcare
assistants (HCAs), who work under the guidance of
the nurses. However, the roles for administrative staff
varied widely, with some practice managers (PMs)
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having an oversight role and some being directly in-
volved in activities such as reminder/recall; some
practices had general administrators with various roles
in managing reminder/recall activities, following up
patients, planning clinics and submitting data, while
others employed specialist administrators with specific
roles, such as data management, target focussed roles
or managing aspects of finance. In other practices, an
assistant practice manager (APM) filled this role.
Most receptionists had a role booking in appoint-
ments and checking patients in on arrival, but in
some practices, they had a large role in reminder/re-
call activities and counselling patients over the phone.
The two components that had the greatest variation
between practices were (i) the mechanism and fre-
quency of reminder/recall activities (Table 4, row 2)
and (ii) the structure of the vaccination appointments,
which varied in length and distribution throughout the
week (Table 4, row 4). Several practices had specific
clinics for vaccination: C (two clinics weekly, one for
babies and one for older children), D and H (one
weekly clinic for babies and children) and F (weekly
baby clinic only). Elsewhere appointments were diffused
throughout the week.
Outputs
The number of childhood vaccination appointments
(Table 1) ranged from 9 to 71 during the 2-week data
collection periods (Table 5). The mean appointment
length across all practices was 15.9 min (range 9.0–
22.0 min). Smaller practices (A and C) had the lon-
gest appointments, and the shortest were observed in
F and H both medium-large practices in rural areas.
We asked clinical staff to add information on any
other issues occurring in the appointment that could
have impacted on time, and no appointments were
Fig. 2 The care delivery value chain for routine vaccinations from the perspective of a primary care practice. (The black arrow shows the process
over time within the GP practice, with activities involving the practice above the line and patient-facing activities below the line. The blue arrow
represents the patient’s interaction with the practice during the process). Activity steps with dashed outline are those where times were sometimes
recorded together with other activities by practices, so timings are less reliable. Timings are mean times calculated across the included practices for
each step
Table 3 Number and type of staff group participating in semi-
structured interviews at each practice
A B C D E F G H J TOTAL
Practice nurse (PN) 2 2 2 2 6 1 3 2 3 23
Healthcare assistant
(HCA)
0 0 0 0 4 0 1 2 0 7
Practice manager
(PM)
1 1 1 1 1 1 1 0 1 8
Administrator
(AD)
0 1 2 1 2 1 1 3 1 12
Receptionist (R) 0 0 1 0 0 0 1 0 0 2
Total 3 4 6 4 13 3 7 7 5 52
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identified that had a significant non-vaccination-related
component.
To estimate the capacity available for vaccination, the
number of children aged 0–4 was divided by an estimate
of the annual number of child appointments (number
during the study period multiplied by 25, equal to 50
working weeks). Practices A and D had the highest num-
ber (1.53 and 1.56 appts/child respectively) and are
small-medium practices in rural areas of low deprivation
with high coverage (Table 2). Practice B had relatively
lower capacity (0.76 appts/child) and slightly lower
coverage. Practice G (large practice in London) also had
lower capacity (0.81 appts/child) and significantly lower
coverage, whereas practice J (large practice with high
number of registered children in London) had higher
capacity (1.24 appts/child) and somewhat higher cover-
age overall.
The number of adult vaccination appointments
ranged from 4 to 26 and are not related to practice
size. The high number of adult vaccination appoint-
ments at practice A was due to a concurrent shingles
campaign (23 of 26 appointments), and practice C
was running a meningococcal ACWY campaign for
adolescents (18 of 22 appointments). Appointment
capacity was estimated by dividing the number of
adults aged 65+ by an estimate of the annual number
of adult appointments. This ranged from 0.04 (prac-
tice E) to 0.57 (practice C) and was not related to
overall performance. This is likely due to the large
number of PPV vaccinations delivered alongside the
seasonal flu campaign, which has been excluded from
this analysis. Observed appointment length ranged
from 6.8 min (E) to 14.1 min (C), with the mean being
10.4 min. Overall mean time spent across the nine
practices for each stage in the CDVC is presented in
Fig. 2.
The mean proportion of total practice vaccination
time (TPVT) spent on non-clinical activities was 59.7%
(range 48.4–67.0%). At most practices (A, B, C, F, G, H),
around two thirds TPVT was spent on non-clinical
work, and in the remainder (D, E, J), it was split evenly.
Practice J was the only location where clinical time
(51.9%) outweighed non-clinical time due to the large
number of childhood appointments.
Fig. 3 A process map of the system of implementing routine vaccination at GP practices in England. Green box = resources; yellow
box = non-clinical/administrative activities and processes; grey box = activity undertaken off GP practice site; blue box = clinical activity
and processes; red outlines = activities and process with direct patient contact. *The Red Book is a paper health record held by a child’s
carers. PGD patient group directive, SMS text message (short message service), PSD patient-specific directive; CHIS Child Health
Information System
Crocker-Buque et al. Implementation Science          (2018) 13:132 Page 8 of 19
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To account for practice size, TPVT was divided by
list size to give time per patient. The relative time per
patient was calculated where the mean time per pa-
tient equalled 1. Practices A and C (smaller practices
with long childhood appointments and a high propor-
tion of non-clinical time) spent the most time on vac-
cination activities, whereas practices E and H spent
relatively little time overall. Figure 4 shows the pro-
portion of TPVT spent by different staff groups with
practice ranked in order of total proportion of time
spent by the PN (from 70.8% at practice E to 32.6% at
practice H). Practice E had a relatively streamlined
and automated administration system, reducing the
overall administration time. Practices E, F and B all
had relatively large proportions of PN time spent on
non-clinical activities, which was primarily due to a
significant role in checking the fridges, stock and or-
dering vaccines. Practice G had a particularly large
proportion of administrative time due to receptionist in-
volvement on reminder/recall activities. Practice H’s sys-
tem of having two PNs and two HCAs in a vaccine clinic
significantly reduced the overall amount of time spent by
the PN. Overall, the PM had relatively small roles in vac-
cination, except in A where they were the only member of
administrative staff and D where they had a large role in
both running searches and submitting data.
Comparison to service requirements
Table 6 maps the provider requirements from the
core service specification and quality standards (QS)
recommended by NICE (except QS5 that relates to
young offenders) [17, 18]. No practices had a focus
on reducing disparities in coverage or interventions to
focus on underserved population groups. Similarly, no
local communication strategies had been implemented
and only practices G and J had patient involvement.
A range of contact, reminder and recall systems were
used for childhood vaccines; however, for adults, most
practices vaccinated only when the patient was at-
tending for another purpose (e.g. health check or for
seasonal flu).
Discussion
This is the first study to evaluate how GP practices or-
ganise the delivery of the routine vaccine programme in
England. We have defined a 14-stage CDVC for vaccin-
ation at primary care level alongside a process map.
Overall, two thirds (59.7%) of activity was spent on ad-
ministrative tasks and there was significant variation in
allocation of activities between clinical and non-clinical
staff, with some models of delivery placing a higher time
burden for administration onto nurses. Doctors were
largely not involved in vaccination. The mean appoint-
ment length for childhood appointments was 2.4 times
the length in the practice with the longest appointments
(C) than the shortest (H). This was due to significant
variation in how appointments were arranged within the
practice’s working week, as well as the fixed appoint-
ment length (10, 15 or 20 min) on the booking system.
The range for adult appointments was narrower but still
Fig. 4 Proportion (%) of total practice vaccination time spent by different staff groups on clinical and non-clinical tasks (PM = practice manager;
APM = assistant practice manager; PN = practice nurse; AD = administrator; R = receptionist; HCA = healthcare assistant)
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Table 6 A comparison between implementation of NHS England requirements and NICE quality standards by practices
Domain Requirement/standard Adherence by practice
Outcome 2.4: to offer immunisation to 100% of eligible
individuals in accordance with guidance.
Childhood: coverage at the large practices G, H
and J is much lower than average and well below
the 95% target.
Adulthood: similarly, coverage at the larger practice
(F, G, H and J) is significantly lower than average.
Equity 2.11: to be able to demonstrate what systems are in
place to address health inequalities and ensure equity
of access to immunisation.
None of the included practices had any specific
interventions or services in place to increase uptake
in any population or demographic groups with
low coverage.
2.11: to have procedures in place to identify and
support those persons who are considered
vulnerable/hard-to-reach
None of the included practices had any specific
system in place to identify vulnerable or hard-to-reach
populations. All practices did follow-up with parents
of all young children who did not attend for
vaccination.
Service delivery 3.6: to provide core programme elements, as
covered in The Green Book.
18 programme elements are described, of which were
met by all practices, except reducing variation (none),
patient involvement (G and J only) and local
communications strategies (nothing, aside from
information provision within practice).
3.10: to address poor uptake for the services
where local delivery is lower than the key
deliverables to reduce the variation in local levels
of performance.
None of the included practices had a system for
accessing, evaluating and discussing data relating to
their immunisation outcomes or focus on reducing
local variation in their local population.
Missed opportunities 3.8: to take every appropriate opportunity to check
vaccination status and offer immunisation to
individuals who may have missed or not fully
completed the national routine schedule.
QS2: children and young people identified as
having missed a childhood vaccination are offered
the outstanding vaccination.
Practices A, E, G and J discussed having a commitment
to opportunistic vaccination. However, this was
primarily for providing adults with singles and PPV
when attending for influenza or other chronic
disease health checks. Children were followed up
more intensively by all practices at earlier ages, leaving
less room for opportunistic vaccination. None of the
practices had a specific strategy or protocol for
reducing missed opportunities.
Consent 3.9: to adhere to The Green Book guidance
on consent.
This was undertaken by all practices.
Assessment 3.10: to have systems in place to assess eligible
individuals for suitability by a competent
individual prior to each immunisation.
QS4: children and young people have their
immunisation status checked at specific educational
stages.
Aside from the use of searches on computer systems
and the general commitment to opportunistic
vaccination by some practices (A, E, G and J), no
specific protocol or plan was used to check immunisation
status. This was especially true for adolescents unless
subject to a specific campaign (e.g. meningitis campaign).
Information systems 3.10: assessed the immunisation record of each
individual to ensure that all vaccinations are up
to date
QS3: children and young people receiving a
vaccination have it recorded in their GP record and
the Child Health Information System (CHIS) and in
their personal child health record.
Record keeping was a high priority for all practices,
although it was found to be time consuming and complex.
3.10: systems in place to identify those in clinical
risk groups and to optimise access for those in
underserved groups
In all practices, the electronic record system was used
to identify patients in clinical risk groups, as per the
schedule; however, no practices used it to identify
people in specific underserved groups.
3.10: arrangements in place to report and
co-ordinate responses to outbreaks of diseases
This was undertaken by all practices.
Reminder, recall 3.10: systems in place to identify, follow up and
offer immunisation to eligible individuals
3.10: arrangements in place that enable them to
identify and recall under- or unimmunised
individuals and to ensure that such individuals
are offered immunisation in a timely manner.
QS1: children and young people who do not
attend their immunisation appointment are
followed up with a written recall invitation and
There was large variation in method and frequency
of patient contact, reminder and recall activities. For
childhood appointments, all practices sent letters first
and used phone calls to follow up non-responders.
Practices A and C sometimes called patients first.
Practices A, C, H and G also used text messages.
All initial patient contacts were made by a receptionist
or administrator and follow-up of non-responders to
non-attenders was sometimes undertaken by the PN
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a more than twofold differential in length (2.1). Total
time spent on vaccination relative to practice size varied
greatly; however, this was not related to overall perform-
ance. Small- to average-sized practices, whether urban
(B, C) or rural (A, D), had better performance overall.
Greater capacity, as measured by appointments per pa-
tient, may be associated with higher coverage in children,
but not for adults, and this requires further investigation.
Fidelity
To further compare and analyse the variation in imple-
mentation between the different practices, we have
drawn on the concept of fidelity, which is defined as ‘the
degree to which programs are implemented as intended
by the program developers’, which acts to modify the
relationship between the intervention (vaccination) and
outcomes (coverage, VPD incidence) [27]. Vaccination is
a long-standing complex public health intervention that
has been modified over time to reflect an emerging
evidence base. Implementation here is defined as ‘a con-
trolled activity aiming to introduce and encourage uptake
of a new policy or intervention that embodies pre-defined
criteria’ [28]. In this context, the controlled activity is pro-
viding the routine vaccination programme and the
pre-defined criteria include national evidence-based policy
and guidelines. Changes to policy and guidelines are out-
side the control of the practices and act as interventions
with variable penetration. This raises the question of im-
plementation fidelity: To explore this further, we have
drawn on the conceptual framework developed by Carroll
et al. as modified by Pérez et al., which considers the
following factors that affect implementation fidelity:
adherence (including content and amount (coverage,
frequency and duration)), moderators (complexity, fa-
cilitation, quality and participant responsiveness) and
adaptation [27, 29].
Adherence
Adherence is defined as whether the programme is de-
livered as it has been designed. The use of evidence by
practices when delivering the programme was variable de-
pending on the content. For the vaccination programme,
there are two relevant elements of content to consider:
the clinical and administrative components. For the clin-
ical component (i.e. the schedule), there was very high ad-
herence from all practices for children. However, this was
much lower for adult vaccines with six practices only vac-
cinating when an eligible patient attended for another
service.
For the administrative components in both adults and
children, there was very variable content adherence, par-
ticularly in terms of reminder/recall activities, communi-
cations and service design (Table 4). A range of systems
was used for contacting patients, most often involving
letters and phone calls (in which administrative and re-
ception staff have a large role) with a smaller number of
practices using text messages, which have good evidence
of effectiveness at increasing coverage [30]. Only two
practices used active recall for adult vaccines (G and J),
despite evidence for interventions that reminder/recall
activities can increase coverage [31]. This creates vari-
ability in the amount of intervention delivered to the
population (sometimes described as the ‘dose’—e.g.
number of reminder letters, availability, frequency and
Table 6 A comparison between implementation of NHS England requirements and NICE quality standards by practices (Continued)
Domain Requirement/standard Adherence by practice
a phone call or text message (A, F, G and J).
For adults, most practices vaccinated opportunistically
when an eligible patient was attending for a check
(e.g. diabetes) or for flu vaccine (C, D, E, F, G and J).
Practices B and H also sent invite letters. Practice A
was alone in phoning older adults.
Vaccine administration 3.12: the provider has a duty to ensure it has, or
will have, trained and competent staff to deliver
(any) given immunisation programme they agree
a contract for
This was undertaken by all practices.
3.12: the professional lead in the provider
organisation must ensure that all staff are legally
able to supply and/or administer the vaccine
This was undertaken by all practices.
Storage and wastage 3.13: have effective cold chain and administrative
protocols that reduce vaccine wastage to a
minimum and reflect national protocols
Responsibilities for maintaining the cold chain was
divided between practices who allowed
administrative staff to do this (C, G and H) and
practices that used the clinical staff
(A, B, D, E, F and J).
Ordering 3.14: centrally procured vaccines must be
ordered via the ImmForm online ordering
system
The distribution of ordering was split similarly to
the requirement above.
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duration of appointments, availability of education mate-
rials). This was particularly important for the larger
practices with lower coverage, which all spent relatively
little time delivering the vaccine programme (F, G, H).
In a large, busy practice with no dedicated clinic (G, J),
patients may have difficulty in accessing appointment
time for vaccination and could have contributed to these
practices’ lower coverage. Despite low coverage for
childhood (G, H and J) and adult (F, G, H and J) vaccina-
tions, no practices had interventions or services in place
to increase uptake in any population or demographic
groups with low coverage and none had community in-
formation or education plans.
Reducing missed opportunities for vaccination (MOV)
features in both the service specification and quality stan-
dards, the practices that did report a commitment to op-
portunistic vaccination (A, E, G and J) did not have a
system of reducing MOV. This could potentially be a suit-
able programme intervention that may increase coverage
without requiring significant increases in capacity (such as
patient tracking or provider prompts), although evidence
is limited for effective interventions [32].
Moderators
Organising vaccination is highly complex and thus is
likely to have lower implementation fidelity as a re-
sult [27]. This in part is because the programme has
evolved over time, rather than implemented from
scratch, but also because some ability for local tai-
loring of the administrative content is planned into
the guidance [17]. This means that the administra-
tive recommendations are less specific than the clin-
ical recommendations, which is known to reduce
likelihood of implementation [33]. Research on NICE
guidelines specifically has shown that initially imple-
mentation is strategic, but as time passes, it becomes
increasingly sporadic and subject to local contextual
factors [28].
Similarly, the facilitation strategies (training, support
and guidance) are more robust for the clinical elements
of the programme. Changes to the vaccine schedule and
guidance in The Green Book are followed closely [34],
particularly via the vaccine update email from Public
Health England [35]. Nurses also undertake annual
training, which is primarily clinical. However, there is no
equivalent guidance for the non-clinical components to
the programme and administrative staff do not receive
any training, despite having a significant patient-facing
role. Aside from outcome data, this study did not collect
any quality metrics from practices, making quality, in
terms of patient experience, difficult to assess. This may
be a significant modifying factor affecting performance.
Of note, the single practice with a low score for friends
and family recommendation (F) also had very poor adult
vaccination coverage (56.1%), suggesting a quality factor
may be important. However, the family and friends test
has been criticised as lacking robust rationale and evi-
dence, so further work is required on relevant service
quality factors for vaccination.
Participant responsiveness is related to a patient’s view
of whether an intervention is useful and relevant to
them, thus affecting uptake. All practices reported some
experience of having parents and patients decline vacci-
nations; however, overall, this was described as being a
relatively minor problem. However, vaccine hesitancy is
an increasing trend in high-income countries and inter-
ventions to reduce hesitancy require specific training to
implement effectively [36, 37]. More common was per-
sistent non-attenders, who either did not respond to let-
ters or calls or booked appointments and did not attend
(DNA). These patients were well known to the practices
and often DNA for other appointment types as well.
There is little research evidence on how to identify and
provide services to improve coverage in persistent
non-attending patients.
Adaptation
Adaptation is the process of an intervention being chan-
ged by an organisation after implementation and may be
a critical component for intervention success [29]. The
clinical component of the programme shows very little
scope for adaptation and is delivered with high fidelity.
However, both task allocation and administrative activ-
ities show relatively high adaptability, as evidenced by
the different organisational structures in place at each of
the practices included here. This is significant as people
management factors within healthcare organisations, in-
cluding role descriptions, performance management,
stress and leadership, are known to impact organisation
effectiveness [38]. It is likely that this adaptation is re-
lated to the specific organisational context of each prac-
tice, which will be explored in a subsequent analysis of
the qualitative data.
Reducing inequities
There are long-standing inequities in vaccination cover-
age in many countries, including England and across
Europe, as a result of vaccine programmes not providing
adequate services to all communities [4, 13, 39–46].
Pockets of under-immunised children and adults are
likely one of the factors to have contributed to the rise
in VPD incidence and outbreaks seen across Europe in
recent years [1, 45]. There is some expectations de-
scribed in both the service specification and quality stan-
dards relating to practices implementing systems to
identify and reduce disparities between local population
groups. However, there is no clear mechanism for this to
be delivered or monitored. Practice staff do not have
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access to data in sufficient detail to be able to assess
local inequities and are unlikely to have the capacity to
design and deliver a bespoke intervention without sup-
port and guidance. This is despite there being evidence
of effectiveness for several categories of interventions to
reduce inequities in low-income, ethnically diverse urban
settings, such as community-designed multi-component
interventions, focussed, escalating reminder-recall activ-
ities or alternative service provision models such as
home visiting [4]. In practice, the responsibility of identi-
fying and addressing inequities in immunisations is
shared among organisations in the public health admin-
istration, where local, regional and national public health
teams are best placed to identify inequities and suggest
evidence-based approaches to addressing them, with
general practice implementing these approaches in order
to vaccinate those underserved communities. However,
since the implementation of the reforms in 2013, data
sharing is more complex and the role of regional vaccin-
ation managers has changed, reducing their ability to
support and evaluate practices’ performance [11]. None
of the practices in this sample had experience of working
with any external organisation in this way.
Capacity
A large review of the organisation and implementation
of health improvement interventions in primary care
identified the strong evidence base for GP practice-led
interventions but also noted the increasing complexity
of public health services commissioning following the
organisation reforms implemented in 2013, including the
contracting arrangements for the vaccine programme
[47]. Relative time spent delivering the vaccination
programme did not appear to have an effect on coverage.
Of the two, large practices in London, practice G spent
slightly less than average time on vaccination during the
study period but had very low rates of coverage overall,
and practice J spent roughly average amount of time
but also had very low coverage. However, higher cap-
acity for children, in terms of appointments per patient,
may be associated with higher coverage. The strength
of this association will need to be evaluated with a lar-
ger study. While one solution may be to expect these
practices to increase the availability or frequency of
vaccination appointments, this may not be possible due
to the multiple competing demands on staff time at a
busy, urban practice with a relatively deprived popula-
tion with high need, without commensurate increases
in funding [9, 48].
Implications for policy
Mandatory reforms of locally determined systems by
national-level bodies are unlikely to be successful given the
level of variation between practices. However, information
relating to variation in staffing structure and task allo-
cation should be distributed to practices to compare
their model and determine if it could be made more ef-
ficient, particularly in terms of allocated appointment
length. The role of administrators and receptionists was
significant, and support in terms of education and
training to this group of professionals could improve
local service delivery. Task shifting, including support
for a greater use of HCAs, could also increase practice
capacity by reducing time spent by nurses. Either add-
itional support needs to be given to practices to imple-
ment strategies to reduce inequities or this function
should be allocated to another branch of the public
health system. Rationalisation of the data collection and
reporting systems required could also reduce the ad-
ministrative time burden on practices.
Strengths and limitations
The strengths of this study include the collection of
standardised information, using multiple methods simul-
taneously, to evaluate implementation of vaccination de-
livery at a broad range of GP practices in England. This
has enabled detailed comparison of GP practice organ-
isation for the first time. Limitations are that this is a
small, convenience sample of practices and thus sub-
ject to selection bias, making them unlikely to be rep-
resentative of the population of GP practices at large,
especially as practices had higher QOF and recommen-
dation scores than average. No very small or very large
practices were included in the sample. The methods
rely on self-reporting of activities, which may be sub-
ject to reporting bias. Activity logs were kept during
different weeks at each practice and activity is not con-
sistent throughout the year. The sample was too small
for further statistical analysis to measure association
effects.
Conclusions
There is variation in how GP practices in England imple-
ment the delivery of the routine vaccination programme.
Areas of greatest variation include the method of re-
minder and recall activities, structure of vaccination ap-
pointments and task allocation between staff groups.
Introduction of organised reminder and recall activities
for adults could improve coverage. Most (60%) activity
was spent on administrative tasks, which had lower fi-
delity of implementation to guidelines and standards.
Implementation of clinical activities had very high fidel-
ity. Appointment length and time spent on vaccination
did not appear to be related to coverage; however, cap-
acity in terms of availability of appointments per patient
could be related and requires further investigation. Fur-
ther work is also required to evaluate other contextual
factors, including the working culture within practices.
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Appendix
Topic guide
Table 7 A modified version of the below guide was used if the interview only had administrative staff
Topic Prompt Notes and possible questions
Welcome and
introduction
Intro - Background to the project
- My role and LSHTM
Scope of interview - Overview of purpose
- Confidentiality
- Topics to be covered
- Time for questions
- Confirm consent
Organisation and role Intro This section is looking to understand how the routine vaccination
programme is organised within your GP practice.
Role and responsibility - Please describe your role within the practice team in delivering
the vaccination programme.
- How long have you been in this position for?
- How much of your working time do you spend on vaccination per week?
Vaccination programme organisation - How is the vaccination programme organised within your GP practice?
- Which other staff members are involved?
Inputs Intro - This section is looking to understand how the practice uses information
to make decisions about how to run the programme.
Information sources and use - What information sources do you use?
- How are you informed of changes to the programme?
- How often to you undertake training?
Data knowledge and management - Where do you get information from relating to your practice’s
performance?
- How often do you receive updates about coverage levels?
Resources (financial and human) - Do you have responsibility for the financial management of the
programme?
- Do you know how the programme is funded?
- Is the funding adequate to provide the programme?
- What do you think about the current system of payments for the
vaccination programme?
Networks - Are you a member of any local or national networks relating to vaccination?
- What organisations do you interact with locally related to vaccination?
- What information do you receive from these sources?
- Do the networks provide any other benefits?
- Which other external organisations (e.g. schools, local government) do you
interact with regularly?
Sensemaking Intro This section is seeking to understand how vaccination is perceived and prioritised
within your practice.
Leadership - Is there an identified person who leads the programme?
- If the leadership role is split, please describe how this works?
- Is leadership important for delivery of the programme in your practice?
Decision-making - Who is responsible for making decision relating to the programme?
- Do you have a regular practice meeting to discuss vaccination? How often?
Who attends?
- Is there a local or regional committee or board that meets? How often?
Who attends?
- How often do you make changes in how you deliver the programme?
Climate and culture - How much of a priority is vaccination when compared to other areas?
- Are staff members and the management supportive of vaccination?
- Could the way your practice organises the programme be improved? If so,
what are the barriers?
Interpersonal relationships - Do staff work together well to deliver the programme?
- Do staff interact with external organisations well?
- Are there any interpersonal barriers to running the programme?
Responses to change - How well does your practice respond to changes in the programme?
- How long does it take changes to the programme to be implemented?
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Table 7 A modified version of the below guide was used if the interview only had administrative staff (Continued)
Topic Prompt Notes and possible questions
Activities and outputs Intro This section is seeking to understand what vaccination activities you undertake
and the uptake of these.
Task allocation - How are roles and responsibilities distributed?
- Is it always clear who is supposed to be doing what?
Time allocation - How much time is dedicated to vaccination?
- Is this enough? Or too much/little?
Systems and processes - Is the way the programme organised suitable?
- Is the system of delivering vaccinations clear to all staff?
- Could it be improved?
- How are incidents reported?
Data collection and submission - How are data collected and submitted?
- What is your role in this process?
- Is it done well? Or could it be improved?
Uptake and access - Is there good uptake of vaccination in your practice?
- Do you think patients have any problems accessing services?
Interventions - Are you involved with any interventions to improve
access/uptake? If so, please describe.
- If no, do you think there would be any role for an intervention at
your practice? If so, for what purpose?
Workload and capacity - How do you find the workload of running the programme?
- Do your colleagues feel the same way?
- Do you have capacity to increase uptake of the programme?
Outcomes Intro This section is seeking to understand what the overall outcomes of
the programme are in your practice.
Patient factors and perception - Do you think the type of population you service makes any
difference to the coverage levels you achieve?
- Do your patients hold any views that affect vaccination coverage?
Community relationship - Is the practice integrated into the local community?
- How do you feel about the patients in your local area?
Coverage levels and performance - Do you know how well your practice performs?
- What indicators do you use?
- Do you feel this could be improved? If so, how?
Wrap up Open space for discussion and
questions
- Has everything been covered?
- Space for any other questions/issues to be raised/discussed.
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